Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
179 | Journal of Stem Cells | journal | 0.102 Q4 | 21 | 4 | 37 | 651 | 2 | 36 | 0.07 | 162.75 | |
178 | European Pharmaceutical Review | trade journal | 0.103 Q4 | 9 | 0 | 27 | 0 | 1 | 24 | 0.00 | 0.00 | |
177 | Chinese Journal of Cancer Biotherapy | journal | 0.106 Q4 | 5 | 18 | 499 | 608 | 36 | 494 | 0.07 | 33.78 | |
176 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.107 Q4 | 14 | 0 | 9 | 0 | 1 | 9 | 0.11 | 0.00 | |
175 | Current Pharmacogenomics and Personalized Medicine | journal | 0.110 Q4 | 20 | 12 | 37 | 381 | 9 | 32 | 0.24 | 31.75 | |
174 | Clinical and Experimental Morphology | journal | 0.123 Q4 | 4 | 32 | 95 | 843 | 30 | 95 | 0.42 | 26.34 | |
173 | Proceedings of the Shevchenko Scientific Society. Medical Sciences | journal | 0.128 Q4 | 4 | 36 | 105 | 861 | 27 | 100 | 0.35 | 23.92 | |
172 | Cellular Therapy and Transplantation | journal | 0.129 Q4 | 8 | 30 | 150 | 916 | 36 | 102 | 0.35 | 30.53 | |
171 | Frontiers in Anti-infective Drug Discovery | book series | 0.131 Q4 | 3 | 0 | 15 | 0 | 7 | 8 | 0.29 | 0.00 | |
170 | Yaoxue Xuebao | journal | 0.146 Q4 | 36 | 395 | 1006 | 18659 | 707 | 1006 | 0.75 | 47.24 | |
169 | Bulletin of Siberian Medicine | journal | 0.147 Q4 | 9 | 94 | 322 | 3269 | 136 | 322 | 0.34 | 34.78 | |
168 | Current Cancer Therapy Reviews | journal | 0.147 Q4 | 17 | 37 | 88 | 1901 | 43 | 79 | 0.52 | 51.38 | |
167 | OBM Genetics | journal | 0.153 Q4 | 4 | 27 | 84 | 1822 | 23 | 77 | 0.22 | 67.48 | |
166 | Tropical Journal of Natural Product Research | journal | 0.155 Q4 | 11 | 324 | 569 | 12540 | 339 | 569 | 0.63 | 38.70 | |
165 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.159 Q4 | 16 | 37 | 119 | 1635 | 67 | 119 | 0.65 | 44.19 | |
164 | VacciMonitor | journal | 0.162 Q4 | 5 | 19 | 56 | 352 | 23 | 51 | 0.40 | 18.53 | |
163 | Current Enzyme Inhibition | journal | 0.174 Q4 | 19 | 22 | 69 | 1028 | 44 | 61 | 0.69 | 46.73 | |
162 | Pteridines | journal | 0.175 Q4 | 19 | 11 | 56 | 414 | 29 | 56 | 0.44 | 37.64 | |
161 | Current Pharmaceutical Analysis | journal | 0.178 Q4 | 27 | 88 | 340 | 4225 | 222 | 335 | 0.64 | 48.01 | |
160 | MCB Molecular and Cellular Biomechanics | journal | 0.180 Q4 | 31 | 20 | 88 | 533 | 47 | 82 | 0.54 | 26.65 | |
159 | Letters in Drug Design and Discovery | journal | 0.192 Q4 | 37 | 89 | 355 | 4304 | 346 | 329 | 1.00 | 48.36 | |
158 | Journal of Medicinal and Chemical Sciences | journal | 0.221 Q4 | 14 | 140 | 112 | 5090 | 184 | 112 | 1.64 | 36.36 | |
157 | Turkish Computational and Theoretical Chemistry | journal | 0.228 Q4 | 8 | 10 | 30 | 327 | 57 | 30 | 2.45 | 32.70 | |
156 | Eurobiotech Journal | journal | 0.230 Q4 | 10 | 17 | 71 | 1286 | 143 | 70 | 1.96 | 75.65 | |
155 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.254 Q4 | 53 | 81 | 224 | 2783 | 342 | 224 | 1.47 | 34.36 | |
154 | Nanomedicine Research Journal | journal | 0.255 Q4 | 20 | 40 | 112 | 2035 | 179 | 112 | 1.49 | 50.88 | |
153 | Current Computer-Aided Drug Design | journal | 0.258 Q4 | 32 | 42 | 195 | 1983 | 312 | 187 | 1.66 | 47.21 | |
152 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.270 Q4 | 45 | 29 | 106 | 1316 | 124 | 100 | 1.09 | 45.38 | |
151 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.298 Q4 | 39 | 20 | 62 | 1174 | 101 | 60 | 1.00 | 58.70 | |
150 | Infectious Disorders - Drug Targets | journal | 0.298 Q4 | 61 | 100 | 328 | 4928 | 482 | 311 | 1.40 | 49.28 | |
149 | Turkish Journal of Pharmaceutical Sciences | journal | 0.303 Q4 | 22 | 89 | 267 | 3368 | 486 | 257 | 1.78 | 37.84 | |
148 | Drug Discovery Today: Disease Models | journal | 0.315 Q4 | 33 | 0 | 30 | 0 | 46 | 26 | 1.83 | 0.00 | |
147 | Expert Review of Precision Medicine and Drug Development | journal | 0.317 Q4 | 16 | 18 | 120 | 1413 | 173 | 94 | 1.04 | 78.50 | |
146 | Journal of Asian Natural Products Research | journal | 0.328 Q4 | 51 | 128 | 407 | 2887 | 738 | 385 | 1.84 | 22.55 | |
145 | Biointerface Research in Applied Chemistry | journal | 0.336 Q4 | 30 | 556 | 1028 | 30346 | 2677 | 1025 | 2.74 | 54.58 | |
144 | Open Medicinal Chemistry Journal | journal | 0.352 Q4 | 23 | 6 | 22 | 464 | 50 | 19 | 2.75 | 77.33 | |
143 | Assay and Drug Development Technologies | journal | 0.358 Q4 | 65 | 34 | 128 | 1424 | 265 | 120 | 1.78 | 41.88 | |
142 | Personalized Medicine | journal | 0.358 Q4 | 36 | 50 | 159 | 2255 | 271 | 146 | 1.99 | 45.10 | |
141 | Nucleus (India) | journal | 0.362 Q4 | 17 | 40 | 106 | 3231 | 206 | 99 | 2.18 | 80.78 | |
140 | Chemistry and Biodiversity | journal | 0.380 Q4 | 83 | 498 | 850 | 22452 | 2585 | 847 | 2.96 | 45.08 | |
139 | International Journal of Peptide Research and Therapeutics | journal | 0.395 Q4 | 45 | 160 | 642 | 8727 | 1561 | 641 | 2.64 | 54.54 | |
138 | Future Cardiology | journal | 0.399 Q4 | 43 | 101 | 267 | 3397 | 402 | 249 | 1.50 | 33.63 | |
137 | Journal of Peptide Science | journal | 0.416 Q4 | 73 | 66 | 174 | 2641 | 357 | 173 | 2.20 | 40.02 | |
136 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.428 Q3 | 108 | 286 | 635 | 21787 | 1751 | 622 | 2.76 | 76.18 | |
135 | SAR and QSAR in Environmental Research | journal | 0.433 Q3 | 54 | 50 | 149 | 2653 | 450 | 149 | 3.18 | 53.06 | |
134 | Pharmacogenomics | journal | 0.435 Q3 | 100 | 98 | 356 | 4115 | 821 | 342 | 2.02 | 41.99 | |
133 | Molecular and Cellular Oncology | journal | 0.436 Q3 | 37 | 17 | 312 | 392 | 347 | 220 | 1.05 | 23.06 | |
132 | Molecular Cytogenetics | journal | 0.443 Q3 | 38 | 52 | 162 | 1641 | 273 | 161 | 1.32 | 31.56 | |
131 | International Journal of Molecular and Cellular Medicine | journal | 0.447 Q3 | 22 | 13 | 83 | 594 | 195 | 82 | 2.29 | 45.69 | |
130 | European Journal of Hybrid Imaging | journal | 0.453 Q3 | 14 | 37 | 71 | 976 | 161 | 68 | 2.32 | 26.38 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®